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The Coodpasture antigen in Alport's syndrome: Studies with a mono-
clonal antibody. A mouse monoclonal antibody (MCA-Pl), which
recognizes an antigenic determinant in human glomerular basement
membrane against which autoantibodies are directed in Goodpasture's
syndrome, was used in indirect immunofluorescence studies to inves-
tigate glomerular basement membrane structure in Alport's syndrome.
We found reduced or absent binding of MCA-Pl to glomerular and
distal tubular basement membranes in renal biopsy tissue from ten
patients with Alport's syndrome. Antiglomerular basement membrane
antibody eluted from the kidneys of a patient who had died from
Goodpasture's syndrome was used to confirm these findings. In con-
trast, there was bright linear fluorescence of MCA-P 1 on glomerular and
tubular basement membranes of normal renal material and renal biopsy
tissue obtained from patients with a variety of glomerulonephritides.
These results suggest an abnormality or a variable quantity of the
immunoreactive autoantigen in the glomerular basement membrane of
patients with Alport's syndrome. Furthermore, MCA-Pl may be of
value in the diagnostic interpretation of renal biopsies from patients
with familial nephritis.
Alport's syndrome [I] is a familial nephropathy, character-
ized clinically by recurrent or persistent hematuria, proteinuria,
the development of renal failure in young adult life and, to a
variable extent, sensori-neural high tone deafness and ocular
defects affecting the lens and macula [21. The disease is usually
expressed in successive generations, but the exact mode of
inheritance may vary, as both autosomal dominant and sex-
linked dominant patterns are described [3]. Males are usually
more severely affected than females within the same kindred
[1], although there is considerable variability in expression of
the disease, especially among females.
Examination of renal tissue by light microscopy (LM) may
show glomerular abnormalities with proliferation of mesangial
cells and matrix or segmental sclerosis; in some patients
tubulointerstitial changes are conspicuous with tubular atrophy,
interstitial foam cells and fibrosis [4]. Direct immunofluores-
cence (IF) is negative or shows focal deposits of 1gM and/or
complement C3 [41. Electron microscopy (EM) characteristi-
cally shows diffuse thickening of the glomerular basement
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membrane (GBM) with irregular inner and outer contours,
associated with splitting of the lamina densa and a characteristic
reticular appearance; areas of thinning of the GBM may also
occur [5]. Several reports have suggested that these
ultrastructural changes may reflect biochemical abnormalities
in the composition of the GBM [6, 7]. Immunological studies
which have attempted to define such a difference have focused
attention on the possible absence of an antigenic component
which is the target of anti-GBM autoantibodies found in pa-
tients with Goodpasture's syndrome. These studies showed
that patients with Alport's syndrome who received a normal
renal allograft occasionally develop anti-GBM antibodies [8, 91,
and that anti-GBM antibodies from patients with Goodpasture's
syndrome may fail to bind to the GBM of Alport's kidneys [7,
8, 10—12].
We have investigated this possibility using a mouse mono-
clonal antibody to human GBM (MCA-Pl) raised in our labo-
ratory, which recognizes the same antigenic component of
GBM as do autoantibodies from patients with Goodpasture's
syndrome [13]. The binding of MCA-P1 has been compared
with that of IgG autoantibody (Goodpasture's eluate; GPE)
eluted from the kidneys of a patient with anti-GBM nephritis.
We have found reduced or absent binding of MCA-P1 to both
GBM and distal tubular basement membrane (TBM) in ten
patients with Alport's syndrome who had strong EM evidence
to support the diagnosis, and we also report our findings in four
patients with hematuria, in whom EM abnormalities of the
GBM were minimal and not diagnostic of Alport's syndrome.
Methods
Patients
We studied ten patients with Alport's syndrome whose
clinical and laboratory findings are shown in Table 1. Criteria
used in making the diagnosis of Alport's syndrome were: (a) the
presence of hematuria in the patient, (b) deafness or specific eye
lesions in the patient, and/or a family history of renal disease or
deafness, and (c) GBM abnormalities on EM consistent with
Alport's syndrome. We also studied four patients in whom the
diagnosis of Alport's syndrome was considered: however, the
ultrastructural appearances, although abnormal, did not sup-
port the diagnosis. They comprized two patients (Cases 11 and
12) with clinical histories suggestive of Alport's syndrome, one
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a Findings on light microscopy graded on a 0 to 3+ scale; findings
Alport's syndrome (D) or abnormal but not supportive (ND).
patient (Case 13) with microscopic hematuria and whose son
(Case 9) had Alport's, and one patient (Case 14) with a clinical
diagnosis of benign familial hematuria.
Kidney biopsy material
Kidney tissue was obtained by percutaneous renal biopsy and
processed for LM, EM and direct IF; some was also stored in
liquid nitrogen for indirect IF studies. Surgical and post mortem
specimens of fresh normal kidney, and biopsy material from 15
patients with other forms of glomerulonephritis, were stored
under the same conditions and used for control studies.
Monoclonal antibodies
The mouse monoclonal antibody to human GBM (MCA-P1)
was produced and characterized as previously described [131.
This antibody binds in a linear pattern to normal GBM, distal
TBM, and Bowman's capsule, the same pattern as observed
with eluted anti-GBM antibody. We have demonstrated corn-
petition between MCA-Pl and autoantibodies in patients' sera
for the autoantigenic determinants in GBM on radioimmuno-
assay and Western blotting (Dash et al, unpublished observa-
tions). MCA-P1 also binds to the basement membrane of the
alveoli, choroid plexus of the brain, lens capsule and choroid of
the eye, and tectorial membrane of the organ of Corti; it does
not bind to basement membrane of the stomach, ileum, gall
bladder, liver, testis, skin, smooth muscle or skeletal muscle
[141. A second mouse monoclonal, of the same subclass as
MCA-Pl but which did not bind to human kidney, was used as
a control.
Human kidney eluate
Human anti-GBM antibodies were obtained by elution with
0.1 M glycine HC1, pH 2,8, from isolated glomeruli of a patient
with anti-GBM nephritis [151. The acid eluate (GPE) was
neutralized with 0.1 M NaOH, concentrated, examined by
single radial immunodiffusion for the presence of IgG and
Table 1. Clinical and laboratory findings in the 14 patients studied
CrCl at
Age of Age of Protein- time of
onset, study, BP uria biopsy
Patient years years Sex mm/Hg Deafness Eyes FH Hematuria g124 hrs mi/mm
1 12 24 M 130/80 — NIE — Macro 2.3 141
2 4 8 M 130/70 + NIE — Macro 3.7 58
3 7 9 M 110/70 — N/E Micro 1.3 91
4 2 12 M 110/70 + + + Macro 2.8 43
5 7 11 M 110/60 + + — Macro 2.0 74
6 31 32 M 145/85 + + + Micro 3.6 23
7 18 27 F 120/80 + + + Micro 3.4 58
8 2 7 M 110/60 + N/E + Macro 0.1 148
9 2 7 M 105/65 + N/E + Micro 0.2 144
10 3 7 M 80/40 + N/E + Micro 0.3 112
11 2 34 F 130/80 + N/E — Micro 3.1 40
12 19 19 M 120/80 N/E + Micro 3.0 127
13 30 30 F 120/80 — N/E + Micro 0 140
14 2 8 M 90/60 — N/F + Macro 0 109
Symbols are: (+) present and (—) absent; N/E, Not examined.
Table 2. Light and electron microscopy findings in the 14 patients studieda
Light microscopy
Mesangium InterstitiumFocal
glomerular Cellular Tubular Electron
Patient sclerosis prolif. Matrix Fibrosis Foam cells Lymphocytes atrophy microscopy
1 0 2+ 2+ 0 + 0 + D
2 + 2+ 2+ 2+ 0 + 0 D
3 0 2+ + 0 + + 0 D
4 + 2+ + + 2+ + + D
5 + 2+ + + + + + D
6 3 obsolete — — 3+ 0 0 3+ D
7 0 2+ + 2+ 0 + D
8 + 2+ + 0 0 0 0 D
9 0 2+ 2+ + 0 0 0 D
10 0 2+ + 0 0 0 0 D
11 + + + + 2+ 0 + ND
12 + 2+ 2+ + 2+ + + ND
13 0 + + 0 0 0 0 ND
14 0 + + 0 0 0 0 ND
on electron microscopy reported as strongly supportive of diagnosis of
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Fig. 1. Electron micrograph < /0,000) of the GBM (arrow heads) in
A/port's syndrome showing diffuse thickening and splitting.
stored at —70°C, for use in indirect immunofluorescence stud-
ies. Acid eluate from glomeruli of normal kidneys was prepared
similarly and used as a control.
Indirect immunofluorescence
Frozen sections of patient's and normal kidney were cut at 4/
to 5p. on a cryostat, air dried, washed in three changes of 0.01
M phosphate buffered saline (PBS), and the fixed sections were
incubated for one hr at room temperature with a 1:10 dilution of
MCA-P1 hybridoma supernatarit or neat GPE. Unrelated
mouse monoclonal antibody and eluate from normal human
kidney were used as negative controls. After washing three
times in PBS for 15 mm, bound antibody was detected by
incubation with fluorescein—linked rabbit anti-mouse IgG or
goat anti-human IgG (Miles Laboratories, Elkharl, Indiana,
USA) at a predetermined optimal dilution for 30 mm at room
temperature. Washing was repeated, and the sections were then
mounted in 90% glycerol in PBS and examined under a fluores-
cence microscope. Intensity of staining was scored on a 0 to 4
scale by two observers (SC, MJK), who did not know the case
histories.
Results
Biopsy findings
The LM findings are shown in Table 2. Direct IF showed
complement C3 in the glomerular capillaries or mcsangium of
eight biopsies, and 1gM within the glomerular capillaries of nine
biopsies; igA, lgG and fibrin were absent. The GBM of all ten
patients with Alport's syndrome showed widespread thickening
and splitting on EM (Fig. 1); limited areas of thinning also
occurred in some patients. Electron microscopy of the (iBM in
Cases II through 14 showed a variety of lesions: Cases 11 and
12 only showed limited areas of thickening, splitting or thinning
of the GBM interspersed with near normal areas, the GBM of
Fig. 2A. Monoclonal antibody MCA-P/, detected hyfluorescein—linked
rabbit anti—mouse IgG, bitids in a linear pattern to normal GBM, distal
TBM and Bowman's capsule. B. A similar pattern is observed with
eluted anti-GBM autoantibody.
Case 13 had slight irregularity of the endothelial border; and the
GBM of Case 14 was diffusely thin.
Indirect inimunofluorescence
The MCA-Pl and eluted anti-GBM antibody bound strongly
to the GBM of normal kidney in a linear pattern, as well as
binding to Bowman's capsule and some distal TBM (Fig. 2),
both were positive to a titer of 1:256; however, staining with
GPE was less intense than that with MCA-P1 and background
fluorescence was higher. Likewise, there was normal staining of
the GBM in kidney biopsies taken from patients with minimal
change, membranous and mesangiocapillary (Type I) glomeru-
lonephritis, systemic lupus erythematosus and diabetes mclii-
tus. The comparative intensity of staining by MCA-Pl and GPE
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Table 3. Comparative intensity of staining of GBM and TBM with
monoclonal antibody MCA-P1 and eluted anti-GBM antibodies (GPE)
in the 14 patients studierja
Binding to GBM Binding to TBM
Patient MCA-Pl GPE MCA-P1 GPE
1 2+ + 0
2 0 0 0 0
3 + + 0 0
4 + + 0 0
5 0 0 0 0
6 + + + +
7 + + + —
8 0 0 0 0
9 0 0 0 0
10 2+ 2+ 2+ 2+
11 4+ 4+ + +
12 4+ 4+ + +
13 4+ 4+ 4+ —
14 4+ 4+ 4+ 4+
a Graded on a 0 to 4+ scale.
on patients' kidney sections is shown in Table 3. Four of the ten
patients (Cases 2, 5, 8, 9) with Alport's syndrome had no
detectable binding to GBM or TBM (Fig. 3A); in the remaining
6 patients there was greatly reduced binding to both GBM and
TBM (Fig. 3B). In Cases 11 and 12 there was normal staining of
the GBM but reduced binding to TBM, and in Cases 13 and 14
the binding was normal. Control mouse monoclonal antibody or
eluate from normal human kidneys bound neither to renal tissue
from normals or from patients with Alport's syndrome.
All four patients with absent binding presented below the age
of seven years and were male. The six patients with reduced
binding to GBM and TBM presented at varying ages between
two and 31, and included one female presenting at 18 years
(Case 7). We were unable to correlate the degree of staining
with severity of renal injury as judged by thickness of GBM at
EM, or by LM; even glomeruli which were almost normal
morphologically could demonstrate absent binding of the MCA.
Nor could we correlate the degree of staining with quantity of
proteinuria or extent of renal impairment. Two patients (Cases
11 and 12) with incomplete evidence of Alport's on clinical and
EM criteria, had normal binding to GBM but markedly reduced
binding to TBM; Case 13, the mother of Case 9, had normal
binding to GBM and TBM as did Case 14, with benign familial
hematuria.
Discussion
In 1973, Spear put forward a hypothesis suggesting that the
genetic abnormality in Alport's syndrome may reside in a
structural gene at a locus governing the composition of base-
ment membranes within the glomerulus, inner ear, and lens
capsule [16]. Ultrastructural abnormalities have been demon-
strated in the GBM [51 and cochlear basement membrane [17] of
patients with Alport's syndrome, and similar abnormalities are
suspected within the basement membrane of the lens and
internal limiting membrane of the retina [2]. Biochemical stud-
ies of GBM from these patients have suggested that there is a
reduction in the hydroxyproline content compared to normal
GBM, implicating an alteration in collagen content as underly-
Fig. 3A. Binding of the monoclonal antibody MCA-P1 to GBM and
distal TBM is absent, or B. considerably reduced in the kidneys of
patients with A/port's syndro,ne.
ing the basement membrane abnormalities. However, indirect
immunofluoresccnce studies using heterologous antisera
showed a normal distribution of Types IV and V collagen (the
main collagen constituents of GBM), as well as laminin, fibro-
nectin and proteoglycan [71.
Reports that anti-GBM autoantibodies fail to bind to the
GBM in some patients with Alport's syndrome have suggested
that absence or alteration of autoantigen may be responsible for
the GBM abnormality [7, 8, 10—121. The development of anti-
GBM antibodies following renal transplantation in four patients
with Alport's supports this argument [8, 9], as does the finding
that the urine of children with Alport's syndrome contains an
antigen which reacts differently to that in the urine of normal
children [18]. However, not all renal biopsies from patients with
clinical and EM findings compatible with Alport's syndrome
have failed to bind anti-GBM antibodies, Of the 40 cases
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Table 4. The presence of Goodpasture antigen in 40 patients with
Alport's syndrome reported in the literatur&'
Source of Linear staining
autoantibody Absent, 20M, 4F Present, 9F, 7 unstated
Serum 17 14
Eluate 7 2
a References 7, 8, 10—12.
reported in the literature (Table 4), kidney biopsies of 24 failed
to stain with anti-GBM antibody in serum (17 cases) or eluted
from glomeruli (seven cases). Twenty of these 24 patients were
male between the ages of three and 22 years, while of the 16
cases whose kidneys showed staining, nine were female and the
sex of the remaining seven were not given. These conflicting
reports may have arisen since most of the studies used serum
antibodies, which cause a high level of background staining
making interpretation difficult. Alternatively, there may be
considerable heterogeneity of inherited nephritis of the Alport
type and/or the degree of binding may reflect sex differences in
the amount of antigen present in the basement membrane, since
most patients with absent binding of Goodpasture serum were
males. To overcome the technical problems inherent in the use
of Goodpasture serum and, to some extent Goodpasture eluate,
we used the monoclonal antibody MCA-P1 to investigate base-
ment membrane antigenicity in patients with Alport's syn-
drome. MCA-Pl produced more intense staining than eluate
with less background, allowing greater definition of the binding
pattern. We hoped that the use of a well—defined probe, which
had been shown to recognize the Goodpasture antigen by solid
phase radioimmunoassay, immunofluorescence and Western
blotting studies, would help determine whether Alport's syn-
drome is a homogeneous or heterogeneous disorder. Studies
have been performed using other monoclonal antibodies to
human GBM in patients with Alport's syndrome [191. These
monoclonals were shown to stain Alport's kidney normally, but
unlike MCA-Pl, none were directed at the autoantigen recog-
nized by human autoantibodies.
Our results showed no staining in four males and substan-
tially reduced staining in the other six patients (5 male, 1
female) with classical Alport's syndrome, though there was no
apparent correlation with the extent of renal injury in this small
number of patients. Nevertheless, these results support the
suggestion that there is a variable quantity of immunoreactive
autoantigen in different patients with Alport's syndrome. The
pattern of binding of MCA-P1 to selected basement membranes
(including cochlea, lens and retina) indicates that the absence of
autoantigen may underline the pattern of organ involvement,
although there is as yet no confirmation from studies using
MCA-P1 on different basement membranes in patients with
Alport's syndrome.
We also found normal binding of MCA-P1 to GBM, but
reduced binding to TBM in cases 11 and 12 who had inconclu-
sive EM evidence for classical Alport's syndrome. The signif-
icance of this pattern is not clear at present, but could represent
incomplete expression of the disease or heterogeneity of inher-
ited nephritis of the Alport type. The latter possibility is
strongly suggested by reports of variability in the inheritance
pattern of Alport's syndrome: sex-linked dominant, autosomal
dominant, and rarely, autosomal recessive forms have been
described [3, 201. The normal binding of MCA-P1 to the GBM
of a mildly affected mother (Case 13) with a severely affected
son in this study is compatible with X-linked transmission of the
disease and variable lyonization (inactivation) of the affected
X-chromosome in the mother. Clearly, it will be necessary to
differentiate female carriers of Alport's syndrome associated
with abnormalities of the Goodpasture antigen (who may have
normal binding of MCA-P1 to GBM) from patients with inher-
ited nephritis and normal binding of MCA-Pl whose abnormal-
ity resides outside of the Goodpasture antigen. Family studies
would help to define more clearly whether absent binding of
MCA-Pl is only associated with a subset of patients who have
X-linked dominant transmission of the disease or whether
abnormalities of the Goodpasture antigen are also associated
with other inheritance patterns. Evidence that MCA-Pl has the
power to differentiate subsets of patients with inherited
nephritis is illustrated in this study by Case 14 who had a
clinico-pathological diagnosis of benign familial hematuria and
normal binding of MCA-P1 to GBM and TBM.
A further application of MCA-Pl would be the development
of an assay system for quantifying the urinary content of GBM
antigen, since GBM antigens are known to be present in urine.
If, as has been suggested [211, the antigen proved to be absent
or reduced in the urine of patients with Alports, this method
would obviate the necessity for renal biopsy in some children
suspected of having Alport's syndrome. Patients with mild
disease could be identified and the possibility that the amount of
antigen present might correlate with prognosis could be inves-
tigated.
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